0000014272-16-000409.txt : 20160505
0000014272-16-000409.hdr.sgml : 20160505
20160505163125
ACCESSION NUMBER: 0000014272-16-000409
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160503
FILED AS OF DATE: 20160505
DATE AS OF CHANGE: 20160505
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO
CENTRAL INDEX KEY: 0000014272
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 220790350
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 345 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10154
BUSINESS PHONE: 2125464000
MAIL ADDRESS:
STREET 1: 345 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10154
FORMER COMPANY:
FORMER CONFORMED NAME: BRISTOL MYERS CO
DATE OF NAME CHANGE: 19891012
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Caforio Giovanni
CENTRAL INDEX KEY: 0001533201
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-01136
FILM NUMBER: 161624303
MAIL ADDRESS:
STREET 1: BRISTOL-MYERS SQUIBB COMPANY
STREET 2: ROUTE 206 & PROVINCELINE ROAD
CITY: LAWRENCEVILLE
STATE: NJ
ZIP: 08543
4
1
wf-form4_146248027193607.xml
FORM 4
X0306
4
2016-05-03
0
0000014272
BRISTOL MYERS SQUIBB CO
BMY
0001533201
Caforio Giovanni
BRISTOL-MYERS SQUIBB COMPANY
345 PARK AVENUE
NEW YORK
NY
10154
1
1
0
0
Chief Executive Officer
Common Stock, $0.10 par value
2016-05-03
4
M
0
21615
27.01
A
132263.3365
D
Common Stock, $0.10 par value
2016-05-03
4
S
0
15145
71.322
D
117118.3365
D
Common Stock, $0.10 par value
2016-05-03
4
M
0
28840
23.12
A
145958.3365
D
Common Stock, $0.10 par value
2016-05-03
4
S
0
19449
71.30
D
126509.3365
D
Option (right to buy)
27.01
2016-05-03
4
M
0
21615
0
D
2017-03-05
Common Stock, $0.10 par value
21615.0
0
D
Option (right to buy)
23.12
2016-05-03
4
M
0
28840
0
D
2018-03-03
Common Stock, $0.10 par value
28840.0
0
D
These shares were sold to cover exercise price and taxes in accordance with broker's procedure for sell-to-cover transactions. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $71.31 to $71.34, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
These shares were sold to cover exercise price and taxes in accordance with broker's procedure for sell-to-cover transactions.
All of the shares are currently exercisable.
/s/ Katherine Kelly, attorney-in-fact for Giovanni Caforio
2016-05-05